Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions



Rating:

Share or cite this content

Citations should be made in the following way:
Y. N. Shanin, O. B. Ilina, I. M. Kuznetsov (St Petersburg, Russian Federation). The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes. Eur Respir J 2006; 28: Suppl. 50, 4305

Member's Comments

No comment yet.

Related content which might interest you: The terms of adaptation of functional systems of patients with lung cancer and secondary inflammatory changes after surgical treatment Source: Eur Respir J 2006; 28: Suppl. 50, 750s Year: 2006 The clinicofunctional features of patients with lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006 The invasive diagnostics of lung cancer with secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 81s Year: 2006 The lung parenchyma in COPD patients: in vitro mechanics and its correlation with inflammatory and structural changes Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Features of an estimation of the functional condition of patients with complicated lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 11s Year: 2004 Impaired oxidant/antioxidant balance and relationships between inflammatory markers and antioxidants in patients with primary lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 86s Year: 2006 Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015 Exercise tests in determination functional system abilities for patients with complicated lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 11s Year: 2005 Relationships between inflammatory markers, response to therapy, and lung function decline Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017 How to define the immune status of lung cancer patient Source: International Congress 2015 – Stop immune tolerance in lung cancer! Year: 2015 Determinants of lung cancer evolution: immune escape and inflammation Source: International Congress 2018 – Scientific Year in Review Year: 2018 Nutritional modulation to correct metabolic alterations in chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Infectional factors influences on expressiveness of inflammatory process and structural changes in bronchial mucosa at COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 A basic prediction model with clinical parameters to diagnose lung cancer. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 The integrated stress response in lung disease Source: International Congress 2015 – Dysfunctional protein quality control in paediatric and adult lung diseases Year: 2015 New approaches to the understanding of complex chronic lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=345 Year: 2006 The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006